Skip to content
10-Q

Quarterly Report

TriSalus Life Sciences, Inc. TLSI TLSIW

0001628280-25-052043

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 49.96M sh
Shares Diluted Q3 2025 · Sep 30, 2025 43.06M sh
Shares Diluted Q3 2025 · Sep 30, 2025 34.86M sh
Shares Diluted Q3 2025 · Sep 30, 2024 26.5M sh
Shares Diluted Q3 2025 · Sep 30, 2024 24.59M sh
Capex Q3 2025 · Sep 30, 2025 $877K
Capex Q3 2025 · Sep 30, 2024 $295K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$15.53M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$35.14M
Long Term Debt Q3 2025 · Sep 30, 2025 $32.76M
Long Term Debt Q3 2025 · Dec 31, 2024 $22.08M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $22.69M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $8.53M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$26.73M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$19.42M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$34.37M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$25.89M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$20.43M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$25.26M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$36.04M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$27.07M
Current Liabilities Q3 2025 · Sep 30, 2025 $10.91M
Current Liabilities Q3 2025 · Dec 31, 2024 $10.23M
Total Liabilities Q3 2025 · Sep 30, 2025 $63.19M
Total Liabilities Q3 2025 · Dec 31, 2024 $49.87M
Current Assets Q3 2025 · Sep 30, 2025 $33.33M
Current Assets Q3 2025 · Dec 31, 2024 $20.67M
Total Assets Q3 2025 · Sep 30, 2025 $36.46M
Total Assets Q3 2025 · Dec 31, 2024 $23.97M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.96
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.72
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.12
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.91
Eps Basic Q3 2025 · Sep 30, 2025 −$0.96
Eps Basic Q3 2025 · Sep 30, 2025 −$1.72
Eps Basic Q3 2025 · Sep 30, 2024 −$0.12
Eps Basic Q3 2025 · Sep 30, 2024 −$0.91
Sga Expense Q3 2025 · Sep 30, 2025 $6.66M
Sga Expense Q3 2025 · Sep 30, 2025 $17.29M
Sga Expense Q3 2025 · Sep 30, 2024 $4.73M
Sga Expense Q3 2025 · Sep 30, 2024 $13.31M
Rd Expense Q3 2025 · Sep 30, 2025 $5.18M
Rd Expense Q3 2025 · Sep 30, 2025 $12.4M
Rd Expense Q3 2025 · Sep 30, 2024 $4.22M
Rd Expense Q3 2025 · Sep 30, 2024 $14.73M
Net Income Q3 2025 · Sep 30, 2025 −$10.81M
Net Income Q3 2025 · Sep 30, 2025 −$29.47M
Net Income Q3 2025 · Jun 30, 2025 −$8.29M
Net Income Q3 2025 · Mar 31, 2025 −$10.38M
Net Income Q3 2025 · Sep 30, 2024 −$2.4M
Net Income Q3 2025 · Sep 30, 2024 −$19.94M
Net Income Q3 2025 · Jun 30, 2024 −$4.33M
Net Income Q3 2025 · Mar 31, 2024 −$13.21M
Operating Income Q3 2025 · Sep 30, 2025 −$9.01M
Operating Income Q3 2025 · Sep 30, 2025 −$23.68M
Operating Income Q3 2025 · Sep 30, 2024 −$8.74M
Operating Income Q3 2025 · Sep 30, 2024 −$28.59M
Gross Profit Q3 2025 · Sep 30, 2025 $9.66M
Gross Profit Q3 2025 · Sep 30, 2025 $26.74M
Gross Profit Q3 2025 · Sep 30, 2024 $6.35M
Gross Profit Q3 2025 · Sep 30, 2024 $18.28M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.91M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $5.2M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $2.89M
Revenue Q3 2025 · Sep 30, 2025 $11.57M
Revenue Q3 2025 · Sep 30, 2025 $31.95M
Revenue Q3 2025 · Sep 30, 2024 $7.35M
Revenue Q3 2025 · Sep 30, 2024 $21.17M